FiercePharma1 小时
2025 forecast: What can AstraZeneca's China probes teach other biopharma companies?
The second and more recent probe involves alleged smuggling of unapproved drugs—the Daiichi-partnered HER2 therapy Enhertu ...
FiercePharma20 小时
From AI and layoffs to supply chains and political unknowns, Deloitte outlines key areas ...
That’s according to the Deloitte U.S. Center for Health Solutions, which found in a recent survey of 150 C-suite executives ...